Literature DB >> 16325553

The burden of MRSA in four German university hospitals.

Iris F Chaberny1, Stefan Ziesing, Frauke Mattner, Sina Bärwolff, Christian Brandt, Tim Eckmanns, Henning Rüden, Dorit Sohr, Klaus Weist, Petra Gastmeier.   

Abstract

In the last few years, a dramatic increase of Methicillin-resistant Staphylococcus aureus (MRSA) detection in German hospitals can be recognized. Under this enormous pressure it is very important for infection control teams to assess the epidemiologic situation correctly. Therefore, a prospective multicenter hospital-based surveillance of MRSA cases was executed in four university hospitals with 1017-1333 beds in Germany. Routine surveillance data were recorded of all patients with MRSA isolates from clinical samples or screening cultures. Patients had been colonized or infected with MRSA during their hospital stay. In 2002 between 183 and 291 MRSA cases were treated in the respective hospitals (between 0.53 and 0.96 MRSA cases per 1000 patient days). Of these, 44.4% were MRSA infections. The most frequent type of MRSA infections were wound infections (56.9%) followed by pneumonia (21.0%) and bloodstream infections (15.1%). Of the infected patients 51.5% were already infected at admission. The median duration of isolation of MRSA patients in private rooms was between 11 and 16 days. Altogether 21,665 isolation days were observed in four hospitals; this means 1.52% of all patient days. On average, 9.0% of roommates were identified as MRSA carriers. Due to the high percentage of imported cases, the four university hospitals introduced a general screening for MRSA at admission in all ICUs and some further departments as well as an automatic alert system for readmitted patient with MRSA during their last hospital stay.

Entities:  

Mesh:

Year:  2005        PMID: 16325553     DOI: 10.1016/j.ijheh.2005.08.004

Source DB:  PubMed          Journal:  Int J Hyg Environ Health        ISSN: 1438-4639            Impact factor:   5.840


  10 in total

Review 1.  Transmission rates, screening methods and costs of MRSA--a systematic literature review related to the prevalence in Germany.

Authors:  A Tübbicke; C Hübner; A Kramer; N-O Hübner; S Fleßa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-05-10       Impact factor: 3.267

2.  [Postoperative wound infections: essentials for the internal medicine].

Authors:  A F Widmer; M Battegay
Journal:  Internist (Berl)       Date:  2010-02       Impact factor: 0.743

3.  Detection of early liver fibrosis in patients with intestinal schistosomiasis: sonographic and histologic findings in Schistosoma mansoni infection.

Authors:  R Chiavaroli; P Grima; P Grima
Journal:  Infection       Date:  2008-11-08       Impact factor: 3.553

4.  Epidemiology of MRSA and current strategies in Europe and Japan.

Authors:  Axel Kramer; Hans Wagenvoort; Christina Ahrén; Inka Daniels-Haardt; Philippe Hartemann; Hiro Kobayashi; Andrea Kurcz; Juan Picazo; Gaetano Privitera; Ojan Assadian
Journal:  GMS Krankenhhyg Interdiszip       Date:  2010-02-10

5.  Implementing the MRSA recommendations made by the Commission for Hospital Hygiene and Infection Prevention (KRINKO) of 1999 - current considerations by the DGKH Management Board.

Authors:  Arne Simon; Martin Exner; Axel Kramer; Steffen Engelhart
Journal:  GMS Krankenhhyg Interdiszip       Date:  2009-04-09

6.  Long-term persistence of MRSA in re-admitted patients.

Authors:  F Mattner; F Biertz; S Ziesing; P Gastmeier; I F Chaberny
Journal:  Infection       Date:  2010-07-03       Impact factor: 3.553

Review 7.  MRSA prevalence in European healthcare settings: a review.

Authors:  Madeleine Dulon; Frank Haamann; Claudia Peters; Anja Schablon; Albert Nienhaus
Journal:  BMC Infect Dis       Date:  2011-05-20       Impact factor: 3.090

8.  A field guide to pandemic, epidemic and sporadic clones of methicillin-resistant Staphylococcus aureus.

Authors:  Stefan Monecke; Geoffrey Coombs; Anna C Shore; David C Coleman; Patrick Akpaka; Michael Borg; Henry Chow; Margaret Ip; Lutz Jatzwauk; Daniel Jonas; Kristina Kadlec; Angela Kearns; Frederic Laurent; Frances G O'Brien; Julie Pearson; Antje Ruppelt; Stefan Schwarz; Elizabeth Scicluna; Peter Slickers; Hui-Leen Tan; Stefan Weber; Ralf Ehricht
Journal:  PLoS One       Date:  2011-04-06       Impact factor: 3.240

Review 9.  Treatment of complicated skin and soft-tissue infections caused by resistant bacteria: value of linezolid, tigecycline, daptomycin and vancomycin.

Authors:  Christian Eckmann; M Dryden
Journal:  Eur J Med Res       Date:  2010-11-30       Impact factor: 2.175

10.  Cost comparison of MRSA screening and management - a decision tree analysis.

Authors:  Andrea Tübbicke; Claudia Hübner; Nils-Olaf Hübner; Christian Wegner; Axel Kramer; Steffen Fleßa
Journal:  BMC Health Serv Res       Date:  2012-12-01       Impact factor: 2.655

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.